ARWR PEER ANALYSIS

Arrowhead Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

ARWRArrowhead Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

ARWRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	ARWR	CSL	TLX	MSB	Ind. Median
P/E	—	30.02	—	—	17.81
P/B	20.08	2.24●	6.56	—	3.49
EV/EBITDA	—	10.37●	123.31	—	14.92
P/S	19.82	2.67●	3.34	31.91	10.89

Financial Health
Metric	ARWR	CSL	TLX	MSB	Ind. Median
Current Ratio	6.23●	2.57	1.43	—	5.90
Debt/Equity	223.7%	67.4%●	112.3%	—	10.9%
NetDebt/EBITDA	3.06	2.22●	13.13	—	1.15

Profitability
Metric	ARWR	CSL	TLX	MSB	Ind. Median
Net Margin	-48.4%	9.2%●	-0.9%	-115.3%	-125.7%
ROE	-46.4%	7.7%●	-1.8%	-11.3%	-47.5%
ROA	-15.7%	3.8%●	-0.7%	-8.6%	-35.8%
EBITDA Margin	-21.6%	32.8%●	3.0%	-76.6%	-105.8%

Growth + Dividend
Metric	ARWR	CSL	TLX	MSB	Ind. Median
Rev. Growth	9.4%	4.8%	56.3%	410.4%●	5.1%
NI Growth	—	-39.4%	—	—	12.1%
Div. Yield	0.3%	2.5%●	—	0.0%	0.2%
Payout	-13.8%	103.1%	—	0.0%	0.0%

Valuation
Metric	ARWR	BMRN	KRYS	AXSM	TECH	KYMR	Ind. Median
P/E	—	43.24●	50.79	—	101.58	—	17.81
P/B	20.08	1.87●	8.95	227.54	5.34	7.27	3.49
EV/EBITDA	—	22.46●	52.90	—	43.46	—	14.92
P/S	19.82	3.58●	27.39	17.54	9.19	217.49	10.89

Financial Health
Metric	ARWR	BMRN	KRYS	AXSM	TECH	KYMR	Ind. Median
Current Ratio	6.23	5.81	9.46	1.39	4.49	10.81●	5.90
Debt/Equity	223.7%	23.2%	0.7%●	402.8%	13.9%	5.2%	10.9%
NetDebt/EBITDA	3.06	-1.62	-4.06●	0.49	0.31	1.86	1.15

Profitability
Metric	ARWR	BMRN	KRYS	AXSM	TECH	KYMR	Ind. Median
Net Margin	-48.4%	8.3%	53.9%●	-26.6%	9.0%	-612.2%	-125.7%
ROE	-46.4%	4.5%	19.9%●	-349.4%	5.3%	-27.1%	-47.5%
ROA	-15.7%	3.4%	18.2%●	-28.7%	4.2%	-24.4%	-35.8%
EBITDA Margin	-21.6%	14.9%	48.1%●	-24.4%	21.3%	-594.7%	-105.8%

Growth + Dividend
Metric	ARWR	BMRN	KRYS	AXSM	TECH	KYMR	Ind. Median
Rev. Growth	9.4%	9.9%	25.1%	63.9%●	0.2%	-12.6%	5.1%
NI Growth	—	-48.7%	81.5%●	—	-16.8%	—	12.1%
Div. Yield	0.3%	—	—	—	0.5%●	—	0.2%
Payout	-13.8%	—	—	—	45.5%	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ARWR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.